WENA
Income statement / Annual
Last year (2023), Anew Medical, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Anew Medical, Inc.'s net income was $1.35 M.
See Anew Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$574,374.00
|
$1.11 M
|
| Selling & Marketing Expenses |
$0.00
|
-$40,382.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.23 M
|
$533,992.00
|
$1.11 M
|
| Other Expenses |
-$75,600.00
|
-$123,030.00
|
$44.00
|
| Operating Expenses |
$1.30 M
|
$657,022.00
|
$1.11 M
|
| Cost And Expenses |
$1.30 M
|
$657,018.00
|
$1.11 M
|
| Interest Income |
$3.36 M
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$24,366.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$44.00
|
| EBITDA |
-$1.30 M |
-$574,227.00 |
-$1.11 M |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$3.34 M
|
$2.13 M
|
$44.00
|
| Income Before Tax |
$2.04 M
|
$1.56 M
|
-$1.11 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
$690,572.00
|
$322,025.00
|
$0.00
|
| Net Income |
$1.35 M
|
$1.23 M
|
-$1.11 M
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
0.14 |
0.0827 |
-0.0855 |
| EPS Diluted |
0.14 |
0.0827 |
-0.0855 |
| Weighted Average Shares Out |
$9.76 M
|
$14.91 M
|
$12.98 M
|
| Weighted Average Shares Out Diluted |
$9.76 M
|
$14.91 M
|
$12.98 M
|
| Link |
|
|
|
